| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.843 | 0.004 | 0.843 | Aldehyde oxidase inhibitor | 0.163 0.128 CID_21349584 | ||
| 0.813 | 0.009 | 0.813 | Caspase 9 stimulant | 0.795 0.012 CID_21349584 | ||
| 0.734 | 0.004 | 0.814 | 5 Hydroxytryptamine release inhibitor | 0.814 0.003 CID_21349584 | CID_21349584 | |
| 0.714 | 0.006 | 0.714 | 5 Hydroxytryptamine release stimulant | 0.557 0.019 CID_21349584 | ||
| 0.68 | 0.005 | 0.79 | Histamine release inhibitor | 0.79 0.004 CID_21349584 | CID_21349584 | |
| 0.644 | 0.003 | 0.644 | Alcohol oxidase inhibitor | 0.079 0.024 CID_21349584 | ||
| 0.649 | 0.013 | 0.805 | Cholesterol antagonist | 0.805 0.004 CID_21349584 | CID_21349584 | |
| 0.636 | 0.004 | 0.636 | Peroxidase inhibitor | |||
| 0.632 | 0.005 | 0.632 | GABA C receptor rho-3 antagonist | |||
| 0.613 | 0.015 | 0.613 | Vasodilator, peripheral | 0.587 0.017 CID_21349584 | ||
| 0.587 | 0.004 | 0.587 | Aldehyde dehydrogenase inhibitor | 0.523 0.004 CID_21349584 | ||
| 0.547 | 0.005 | 0.547 | Anesthetic general | 0.525 0.006 CID_21349584 | ||
| 0.541 | 0.01 | 0.541 | Superoxide dismutase inhibitor | |||
| 0.531 | 0.01 | 0.547 | Vasodilator | 0.547 0.009 CID_21349584 | CID_21349584 | |
| 0.5 | 0.004 | 0.5 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.463 | 0.007 | 0.463 | Phospholipase C inhibitor | 0.373 0.012 CID_21349584 | ||
| 0.446 | 0.011 | 0.599 | Cyclic AMP phosphodiesterase inhibitor | 0.599 0.004 CID_21349584 | CID_21349584 | |
| 0.449 | 0.021 | 0.749 | Hypoglycemic | 0.749 0.004 CID_21349584 | CID_21349584 | |
| 0.45 | 0.031 | 0.57 | Spasmolytic | 0.57 0.016 CID_21349584 | CID_21349584 | |
| 0.443 | 0.028 | 0.443 | Lipoxygenase inhibitor | |||
| 0.427 | 0.016 | 0.427 | Calcium channel activator | 0.217 0.189 CID_21349584 | ||
| 0.43 | 0.027 | 0.644 | Vasodilator, coronary | 0.644 0.006 CID_21349584 | CID_21349584 | |
| 0.443 | 0.055 | 0.443 | Calcium channel L-type activator | |||
| 0.43 | 0.042 | 0.815 | Antithrombotic | 0.815 0.004 CID_21349584 | CID_21349584 | |
| 0.396 | 0.009 | 0.642 | Alpha-N-acetylglucosaminidase inhibitor | 0.642 0.004 CID_21349584 | CID_21349584 | |
| 0.4 | 0.014 | 0.4 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.417 | 0.032 | 0.679 | Antioxidant | 0.679 0.007 CID_21349584 | CID_21349584 | |
| 0.394 | 0.01 | 0.722 | Amylase inhibitor | 0.722 0.003 CID_21349584 | CID_21349584 | |
| 0.427 | 0.058 | 0.723 | Transcription factor NF kappa B inhibitor | 0.723 0.018 CID_21349584 | CID_21349584 | |
| 0.388 | 0.021 | 0.388 | Sodium/bile acid cotransporter inhibitor | 0.314 0.067 CID_21349584 | ||
| 0.393 | 0.03 | 0.609 | Free radical scavenger | 0.609 0.008 CID_21349584 | CID_21349584 | |
| 0.395 | 0.04 | 0.395 | 12-Lipoxygenase inhibitor | |||
| 0.353 | 0.005 | 0.353 | Succinate dehydrogenase inhibitor | 0.195 0.053 CID_21349584 | ||
| 0.349 | 0.005 | 0.349 | Estrogen antagonist | 0.111 0.072 CID_21349584 | ||
| 0.351 | 0.009 | 0.351 | Anesthetic local | |||
| 0.354 | 0.014 | 0.647 | Monophenol monooxygenase inhibitor | 0.647 0.004 CID_21349584 | CID_21349584 | |
| 0.342 | 0.004 | 0.342 | Creatine kinase inhibitor | 0.084 0.08 CID_21349584 | ||
| 0.347 | 0.009 | 0.354 | Neurotrophic factor enhancer | 0.354 0.009 CID_21349584 | CID_21349584 | |
| 0.341 | 0.005 | 0.341 | Carbonic anhydrase XV inhibitor | |||
| 0.417 | 0.082 | 0.842 | Cyclophilin D inhibitor | 0.842 0.005 CID_21349584 | CID_21349584 | |
| 0.345 | 0.017 | 0.53 | Melanin inhibitor | 0.53 0.006 CID_21349584 | CID_21349584 | |
| 0.335 | 0.015 | 0.335 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.262 0.037 CID_21349584 | ||
| 0.317 | 0.005 | 0.317 | Estrogen receptor beta antagonist | |||
| 0.348 | 0.036 | 0.439 | Hypolipemic | 0.439 0.019 CID_21349584 | CID_21349584 | |
| 0.321 | 0.012 | 0.321 | Insulin sensitizer | 0.311 0.014 CID_21349584 | ||
| 0.316 | 0.017 | 0.399 | Lipid peroxidase inhibitor | 0.399 0.009 CID_21349584 | CID_21349584 | |
| 0.408 | 0.11 | 0.626 | Apoptosis agonist | 0.626 0.044 CID_21349584 | CID_21349584 | |
| 0.305 | 0.013 | 0.305 | Phospholipase A2 inhibitor | 0.266 0.019 CID_21349584 | ||
| 0.3 | 0.011 | 0.3 | Nitric-oxide synthase stimulant | 0.299 0.011 CID_21349584 | ||
| 0.328 | 0.04 | 0.328 | Amyloid beta aggregation inhibitor | 0.177 0.09 CID_21349584 | ||
| 0.373 | 0.087 | 0.373 | 15-Lipoxygenase inhibitor | |||
| 0.345 | 0.061 | 0.365 | Caspase 3 stimulant | 0.365 0.054 CID_21349584 | CID_21349584 | |
| 0.298 | 0.017 | 0.474 | Protein kinase stimulant | 0.474 0.005 CID_21349584 | CID_21349584 | |
| 0.3 | 0.02 | 0.476 | Interferon gamma antagonist | 0.476 0.007 CID_21349584 | CID_21349584 | |
| 0.29 | 0.011 | 0.457 | UDP-glucose 4-epimerase inhibitor | 0.457 0.004 CID_21349584 | CID_21349584 | |
| 0.343 | 0.066 | 0.593 | Immunostimulant | 0.593 0.017 CID_21349584 | CID_21349584 | |
| 0.316 | 0.04 | 0.474 | Interleukin agonist | 0.474 0.011 CID_21349584 | CID_21349584 | |
| 0.318 | 0.043 | 0.818 | Angiogenesis stimulant | 0.818 0.004 CID_21349584 | CID_21349584 | |
| 0.279 | 0.007 | 0.279 | Carbonic anhydrase III inhibitor | 0.159 0.025 CID_21349584 | ||
| 0.353 | 0.085 | 0.353 | Calpain 2 inhibitor | |||
| 0.278 | 0.012 | 0.278 | Cystathionine beta-synthase inhibitor | 0.235 0.017 CID_21349584 | ||
| 0.306 | 0.041 | 0.315 | Psychostimulant | 0.315 0.039 CID_21349584 | CID_21349584 | |
| 0.268 | 0.009 | 0.268 | Farnesoid X receptor antagonist | 0.123 0.097 CID_21349584 | ||
| 0.345 | 0.089 | 0.549 | Immunosuppressant | 0.549 0.021 CID_21349584 | CID_21349584 | |
| 0.262 | 0.01 | 0.262 | GABA C receptor rho-2 antagonist | |||
| 0.284 | 0.032 | 0.378 | DNA methyltransferase I inhibitor | 0.378 0.011 CID_21349584 | CID_21349584 | |
| 0.255 | 0.006 | 0.255 | Estrogen agonist | 0.091 0.02 CID_21349584 | ||
| 0.261 | 0.014 | 0.261 | 5-Lipoxygenase inhibitor | |||
| 0.281 | 0.036 | 0.281 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 CID_21349584 | ||
| 0.255 | 0.012 | 0.378 | Xanthine oxidase inhibitor | 0.378 0.005 CID_21349584 | CID_21349584 | |
| 0.257 | 0.017 | 0.257 | Cholesterol synthesis inhibitor | 0.183 0.031 CID_21349584 | ||
| 0.322 | 0.084 | 0.322 | Thyroid hormone antagonist | |||
| 0.263 | 0.025 | 0.263 | MAO inhibitor | |||
| 0.239 | 0.005 | 0.239 | Phosphodiesterase V inhibitor | |||
| 0.292 | 0.058 | 0.292 | Transcription factor STAT3 inhibitor | |||
| 0.243 | 0.009 | 0.622 | Cyclooxygenase 3 inhibitor | 0.622 0.002 CID_21349584 | CID_21349584 | |
| 0.246 | 0.014 | 0.246 | Interleukin 4 antagonist | 0.185 0.027 CID_21349584 | ||
| 0.311 | 0.078 | 0.532 | Apoptosis antagonist | 0.532 0.016 CID_21349584 | CID_21349584 | |
| 0.24 | 0.007 | 0.351 | Photosensitizer | 0.351 0.004 CID_21349584 | CID_21349584 | |
| 0.237 | 0.005 | 0.237 | Macrophage migration inhibitory factor inhibitor | |||
| 0.238 | 0.009 | 0.238 | Arachidonic acid antagonist | 0.195 0.038 CID_21349584 | ||
| 0.249 | 0.021 | 0.249 | MAO A inhibitor | |||
| 0.23 | 0.005 | 0.23 | Phosphodiesterase 5A inhibitor | |||
| 0.232 | 0.008 | 0.232 | GABA C receptor antagonist | |||
| 0.228 | 0.005 | 0.228 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.276 | 0.053 | 0.437 | DNA synthesis inhibitor | 0.437 0.018 CID_21349584 | CID_21349584 | |
| 0.236 | 0.014 | 0.236 | Bronchodilator | |||
| 0.232 | 0.011 | 0.59 | Mediator release inhibitor | 0.59 0.004 CID_21349584 | CID_21349584 | |
| 0.262 | 0.042 | 0.382 | DNA methylase inhibitor | 0.382 0.012 CID_21349584 | CID_21349584 | |
| 0.259 | 0.039 | 0.528 | Non-steroidal antiinflammatory agent | 0.528 0.005 CID_21349584 | CID_21349584 | |
| 0.231 | 0.013 | 0.231 | Toll-Like receptor 2 antagonist | |||
| 0.352 | 0.135 | 0.606 | Alpha-glucosidase inhibitor | 0.606 0.053 CID_21349584 | CID_21349584 | |
| 0.227 | 0.01 | 0.227 | Alcohol dehydrogenase inhibitor | 0.171 0.016 CID_21349584 | ||
| 0.222 | 0.004 | 0.243 | Glutamate release inhibitor | 0.243 0.004 CID_21349584 | CID_21349584 | |
| 0.223 | 0.007 | 0.223 | Estrogen receptor alpha antagonist | |||
| 0.31 | 0.097 | 0.31 | Prostaglandin dehydrogenase inhibitor | |||
| 0.24 | 0.027 | 0.24 | Bone formation stimulant | 0.159 0.053 CID_21349584 | ||
| 0.219 | 0.006 | 0.219 | Prolactin inhibitor | |||
| 0.22 | 0.007 | 0.22 | Adenylate cyclase stimulant | 0.159 0.049 CID_21349584 | ||
| 0.279 | 0.066 | 0.309 | DNA damaging | 0.309 0.054 CID_21349584 | CID_21349584 | |
| 0.223 | 0.011 | 0.227 | Carbonic anhydrase XIII inhibitor | 0.227 0.011 CID_21349584 | CID_21349584 | |
| 0.236 | 0.024 | 0.236 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.213 | 0.002 | 0.213 | Estrogen-related receptor beta agonist | 0.079 0.07 CID_21349584 | ||
| 0.22 | 0.01 | 0.23 | Mucolytic | 0.23 0.008 CID_21349584 | CID_21349584 | |
| 0.225 | 0.016 | 0.569 | Expectorant | 0.569 0.003 CID_21349584 | CID_21349584 | |
| 0.216 | 0.006 | 0.216 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.355 | 0.146 | 0.355 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.283 | 0.074 | 0.314 | Hypoxia-inducible factor 1 alpha inhibitor | 0.314 0.059 CID_21349584 | CID_21349584 | |
| 0.218 | 0.011 | 0.218 | Carbonic anhydrase VI inhibitor | 0.092 0.045 CID_21349584 | ||
| 0.22 | 0.013 | 0.22 | CF transmembrane conductance regulator agonist | 0.162 0.056 CID_21349584 | ||
| 0.219 | 0.013 | 0.219 | Adenylate kinase inhibitor | 0.176 0.019 CID_21349584 | ||
| 0.22 | 0.014 | 0.22 | Nav1.6 sodium channel blocker | |||
| 0.278 | 0.073 | 0.278 | Insulysin inhibitor | |||
| 0.225 | 0.022 | 0.371 | ATPase inhibitor | 0.371 0.004 CID_21349584 | CID_21349584 | |
| 0.294 | 0.091 | 0.294 | Thyroid hormone beta antagonist | |||
| 0.272 | 0.072 | 0.272 | Transcription factor STAT inhibitor | |||
| 0.261 | 0.063 | 0.261 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.269 | 0.07 | 0.269 | Cardiotonic | 0.165 0.158 CID_21349584 | ||
| 0.248 | 0.052 | 0.428 | Peptidyltransferase inhibitor | 0.428 0.005 CID_21349584 | CID_21349584 | |
| 0.263 | 0.067 | 0.445 | Platelet antagonist | 0.445 0.02 CID_21349584 | CID_21349584 | |
| 0.208 | 0.014 | 0.208 | Catalase inhibitor | |||
| 0.238 | 0.045 | 0.238 | P-glycoprotein inhibitor | 0.216 0.055 CID_21349584 | ||
| 0.209 | 0.019 | 0.209 | GABA C receptor agonist | |||
| 0.198 | 0.01 | 0.198 | Sphingomyelinase inhibitor | 0.183 0.014 CID_21349584 | ||
| 0.199 | 0.012 | 0.199 | Porphobilinogen synthase inhibitor | |||
| 0.209 | 0.023 | 0.209 | MAO B inhibitor | |||
| 0.191 | 0.004 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.185 0.005 CID_21349584 | ||
| 0.197 | 0.011 | 0.422 | Triose-phosphate isomerase inhibitor | 0.422 0.003 CID_21349584 | CID_21349584 | |
| 0.198 | 0.013 | 0.198 | Histidine decarboxylase inhibitor | |||
| 0.214 | 0.03 | 0.214 | Nav1.2 sodium channel blocker | |||
| 0.193 | 0.009 | 0.193 | Keratolytic | |||
| 0.216 | 0.033 | 0.301 | Interleukin 6 antagonist | 0.301 0.015 CID_21349584 | CID_21349584 | |
| 0.186 | 0.005 | 0.28 | Phosphodiesterase 6D inhibitor | 0.28 0.003 CID_21349584 | CID_21349584 | |
| 0.189 | 0.007 | 0.189 | Peroxisome proliferator-activated receptor gamma agonist | 0.122 0.02 CID_21349584 | ||
| 0.275 | 0.094 | 0.46 | Interleukin 2 agonist | 0.46 0.014 CID_21349584 | CID_21349584 | |
| 0.251 | 0.071 | 0.344 | Antiamyloidogenic | 0.344 0.04 CID_21349584 | CID_21349584 | |
| 0.243 | 0.064 | 0.243 | Interleukin antagonist | |||
| 0.19 | 0.012 | 0.319 | Phosphofructokinase-1 inhibitor | 0.319 0.005 CID_21349584 | CID_21349584 | |
| 0.199 | 0.022 | 0.199 | Antibacterial (Helicobacter pylori) | 0.119 0.083 CID_21349584 | ||
| 0.253 | 0.076 | 0.253 | Gastrin inhibitor | 0.217 0.123 CID_21349584 | ||
| 0.208 | 0.031 | 0.208 | Neurotensin receptor agonist | |||
| 0.306 | 0.13 | 0.651 | Antibacterial | 0.651 0.013 CID_21349584 | CID_21349584 | |
| 0.19 | 0.015 | 0.19 | Vanilloid 1 agonist | 0.171 0.023 CID_21349584 | ||
| 0.184 | 0.011 | 0.184 | GABA C receptor rho-1 antagonist | |||
| 0.238 | 0.065 | 0.238 | Pyruvate kinase inhibitor | |||
| 0.185 | 0.013 | 0.185 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.239 | 0.067 | 0.239 | Neuropeptide Y2 antagonist | |||
| 0.232 | 0.062 | 0.232 | ErbB-1 antagonist | |||
| 0.179 | 0.011 | 0.179 | DOPA decarboxylase inhibitor | |||
| 0.205 | 0.04 | 0.205 | Acetylcholine M1 receptor antagonist | |||
| 0.17 | 0.005 | 0.17 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.219 | 0.055 | 0.531 | Hepatoprotectant | 0.531 0.006 CID_21349584 | CID_21349584 | |
| 0.188 | 0.025 | 0.188 | Ferrochelatase inhibitor | |||
| 0.222 | 0.06 | 0.473 | Platelet adhesion inhibitor | 0.473 0.006 CID_21349584 | CID_21349584 | |
| 0.17 | 0.009 | 0.17 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.191 | 0.031 | 0.195 | DNA polymerase I inhibitor | 0.195 0.03 CID_21349584 | CID_21349584 | |
| 0.17 | 0.011 | 0.17 | Adrenaline agonist | |||
| 0.175 | 0.017 | 0.175 | TRPA1 agonist | 0.11 0.072 CID_21349584 | ||
| 0.167 | 0.01 | 0.167 | Glutamate decarboxylase inhibitor | |||
| 0.167 | 0.01 | 0.167 | Anabolic | 0.11 0.049 CID_21349584 | ||
| 0.21 | 0.055 | 0.21 | Histone acetyltransferase inhibitor | |||
| 0.168 | 0.014 | 0.343 | NADH dehydrogenase inhibitor | 0.343 0.006 CID_21349584 | CID_21349584 | |
| 0.156 | 0.005 | 0.156 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.183 | 0.032 | 0.361 | Alkylator | 0.361 0.009 CID_21349584 | CID_21349584 | |
| 0.157 | 0.006 | 0.157 | Glycine receptor agonist | 0.134 0.009 CID_21349584 | ||
| 0.169 | 0.019 | 0.169 | Gastric antisecretory | |||
| 0.157 | 0.009 | 0.157 | Leukotriene antagonist | 0.142 0.011 CID_21349584 | ||
| 0.186 | 0.038 | 0.2 | Mannose-6-phosphate isomerase inhibitor | 0.2 0.031 CID_21349584 | CID_21349584 | |
| 0.153 | 0.007 | 0.153 | Xanthine dehydrogenase inhibitor | 0.075 0.027 CID_21349584 | ||
| 0.178 | 0.033 | 0.178 | Nav1.3 sodium channel blocker | |||
| 0.183 | 0.038 | 0.379 | Cell wall synthesis inhibitor | 0.379 0.007 CID_21349584 | CID_21349584 | |
| 0.229 | 0.085 | 0.229 | Calpain inhibitor | |||
| 0.155 | 0.012 | 0.155 | Histamine N-methyltransferase inhibitor | |||
| 0.149 | 0.006 | 0.149 | Beta adrenoreceptor antagonist | |||
| 0.176 | 0.033 | 0.176 | Neuropeptide Y1 antagonist | |||
| 0.152 | 0.01 | 0.152 | Phosphodiesterase III inhibitor | |||
| 0.144 | 0.004 | 0.144 | Sphingosine kinase 2 inhibitor | |||
| 0.151 | 0.011 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.163 | 0.024 | 0.168 | Heat shock protein 70 antagonist | 0.168 0.019 CID_21349584 | CID_21349584 | |
| 0.162 | 0.023 | 0.244 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.244 0.01 CID_21349584 | CID_21349584 | |
| 0.142 | 0.004 | 0.142 | Squalene epoxidase inhibitor | 0.067 0.015 CID_21349584 | ||
| 0.167 | 0.03 | 0.167 | Chelator | |||
| 0.161 | 0.024 | 0.161 | Potassium channel (Ca-activated) activator | |||
| 0.155 | 0.018 | 0.193 | Toll-Like receptor 4 antagonist | 0.193 0.007 CID_21349584 | CID_21349584 | |
| 0.143 | 0.007 | 0.16 | Phosphodiesterase VI inhibitor | 0.16 0.005 CID_21349584 | CID_21349584 | |
| 0.142 | 0.006 | 0.142 | Beta 3 adrenoreceptor antagonist | |||
| 0.151 | 0.016 | 0.161 | Acetylcholine release stimulant | 0.161 0.011 CID_21349584 | CID_21349584 | |
| 0.186 | 0.053 | 0.186 | Protein-tyrosine phosphatase inhibitor | 0.175 0.059 CID_21349584 | ||
| 0.15 | 0.017 | 0.15 | ABCA1 expression enhancer | |||
| 0.144 | 0.013 | 0.144 | Ornithine decarboxylase inhibitor | 0.12 0.025 CID_21349584 | ||
| 0.139 | 0.01 | 0.139 | Carbonic anhydrase VB inhibitor | |||
| 0.161 | 0.033 | 0.161 | Aminopeptidase B inhibitor | |||
| 0.132 | 0.004 | 0.132 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.134 | 0.007 | 0.134 | Phosphodiesterase 3B inhibitor | |||
| 0.137 | 0.01 | 0.137 | Acyl-CoA dehydrogenase inhibitor | 0.074 0.025 CID_21349584 | ||
| 0.188 | 0.062 | 0.188 | Mcl-1 antagonist | |||
| 0.134 | 0.008 | 0.134 | Estrogen receptor beta agonist | |||
| 0.13 | 0.005 | 0.13 | Phosphodiesterase 1C inhibitor | |||
| 0.136 | 0.011 | 0.136 | Bile acid receptor antagonist | 0.099 0.051 CID_21349584 | ||
| 0.204 | 0.079 | 0.204 | Platelet aggregation inhibitor | 0.161 0.115 CID_21349584 | ||
| 0.236 | 0.112 | 0.236 | Streptokinase A inhibitor | |||
| 0.165 | 0.04 | 0.178 | Protein-tyrosine phosphatase 1B inhibitor | 0.178 0.035 CID_21349584 | CID_21349584 | |
| 0.129 | 0.005 | 0.129 | Potassium channel Kv1.3 blocker | |||
| 0.158 | 0.033 | 0.158 | Falcipain 3 inhibitor | |||
| 0.13 | 0.006 | 0.13 | Beta 1 adrenoreceptor antagonist | |||
| 0.151 | 0.027 | 0.151 | Caspase 3 inhibitor | |||
| 0.126 | 0.003 | 0.126 | Delayed rectifier potassium channel blocker | |||
| 0.148 | 0.026 | 0.148 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.146 | 0.024 | 0.192 | Uric acid excretion stimulant | 0.192 0.014 CID_21349584 | CID_21349584 | |
| 0.126 | 0.005 | 0.126 | Sphingosine kinase inhibitor | |||
| 0.134 | 0.013 | 0.134 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 CID_21349584 | ||
| 0.142 | 0.021 | 0.142 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.137 | 0.017 | 0.145 | Interleukin 12 antagonist | 0.145 0.014 CID_21349584 | CID_21349584 | |
| 0.135 | 0.016 | 0.135 | Glutathione S-transferase inhibitor | 0.079 0.062 CID_21349584 | ||
| 0.132 | 0.014 | 0.201 | Interferon agonist | 0.201 0.006 CID_21349584 | CID_21349584 | |
| 0.138 | 0.02 | 0.138 | Phosphodiesterase I inhibitor | |||
| 0.123 | 0.006 | 0.123 | Beta 2 adrenoreceptor antagonist | |||
| 0.171 | 0.055 | 0.364 | Insulin secretagoues | 0.364 0.008 CID_21349584 | CID_21349584 | |
| 0.185 | 0.068 | 0.185 | Amyloid beta precursor protein antagonist | |||
| 0.171 | 0.055 | 0.171 | Heat shock protein 90 antagonist | |||
| 0.18 | 0.064 | 0.18 | Antipruritic | |||
| 0.138 | 0.023 | 0.138 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.118 | 0.004 | 0.118 | Dopamine D5 agonist | |||
| 0.122 | 0.008 | 0.122 | Dopamine D2 agonist | 0.047 0.029 CID_21349584 | ||
| 0.186 | 0.073 | 0.448 | Nitric oxide antagonist | 0.448 0.02 CID_21349584 | CID_21349584 | |
| 0.177 | 0.064 | 0.177 | Heat shock protein 90 alpha antagonist | |||
| 0.149 | 0.038 | 0.2 | Microtubule formation inhibitor | 0.2 0.02 CID_21349584 | CID_21349584 | |
| 0.118 | 0.009 | 0.118 | Peroxisome proliferator-activated receptor alpha agonist | 0.077 0.019 CID_21349584 | ||
| 0.157 | 0.049 | 0.157 | MAP kinase kinase 4 inhibitor | |||
| 0.154 | 0.046 | 0.154 | Pregnane X receptor agonist | |||
| 0.145 | 0.036 | 0.279 | DNA repair enzyme inhibitor | 0.279 0.005 CID_21349584 | CID_21349584 | |
| 0.134 | 0.027 | 0.134 | Electrolyte absorption antagonist | |||
| 0.114 | 0.007 | 0.114 | Estrogen receptor alpha agonist | |||
| 0.177 | 0.07 | 0.177 | MAP kinase kinase 5 inhibitor | |||
| 0.118 | 0.011 | 0.118 | Acetylcholine M5 receptor agonist | |||
| 0.115 | 0.008 | 0.18 | Leukotriene B4 antagonist | 0.18 0.004 CID_21349584 | CID_21349584 | |
| 0.117 | 0.011 | 0.117 | Phosphodiesterase 1B inhibitor | |||
| 0.11 | 0.004 | 0.11 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 CID_21349584 | ||
| 0.126 | 0.02 | 0.126 | Carbonic anhydrase V inhibitor | |||
| 0.151 | 0.045 | 0.151 | Cathepsin H inhibitor | |||
| 0.136 | 0.032 | 0.136 | Urease inhibitor | |||
| 0.113 | 0.011 | 0.113 | Glycine transporter 2 inhibitor | |||
| 0.112 | 0.01 | 0.112 | GABA B receptor agonist | |||
| 0.11 | 0.008 | 0.11 | Glutamate (mGluR6) antagonist | 0.075 0.03 CID_21349584 | ||
| 0.105 | 0.004 | 0.105 | Leukotriene C antagonist | 0.064 0.022 CID_21349584 | ||
| 0.173 | 0.071 | 0.173 | Growth hormone agonist | |||
| 0.131 | 0.03 | 0.131 | Calcium antagonist | |||
| 0.111 | 0.011 | 0.111 | Potassium channel (ATP-sensitive) blocker | |||
| 0.122 | 0.022 | 0.122 | Interleukin 5 antagonist | 0.109 0.033 CID_21349584 | ||
| 0.117 | 0.018 | 0.117 | Leukotriene synthesis inhibitor | |||
| 0.125 | 0.026 | 0.125 | Toll-Like receptor 3 antagonist | |||
| 0.107 | 0.009 | 0.107 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.137 | 0.039 | 0.137 | Nav1.1 sodium channel blocker | |||
| 0.151 | 0.054 | 0.151 | NADPH oxidase inhibitor | 0.112 0.094 CID_21349584 | ||
| 0.11 | 0.014 | 0.11 | Purinergic P2X1 antagonist | 0.057 0.048 CID_21349584 | ||
| 0.131 | 0.035 | 0.131 | Electron transport complex I inhibitor | |||
| 0.1 | 0.005 | 0.1 | Dihydropteroate synthase inhibitor | |||
| 0.107 | 0.012 | 0.107 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.054 CID_21349584 | ||
| 0.116 | 0.021 | 0.116 | Dopamine agonist | |||
| 0.113 | 0.018 | 0.113 | D-Ala-D-Ala ligase inhibitor | |||
| 0.111 | 0.016 | 0.111 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.116 | 0.022 | 0.116 | Myeloperoxidase inhibitor | |||
| 0.116 | 0.024 | 0.116 | Glutamate dehydrogenase inhibitor | 0.087 0.039 CID_21349584 | ||
| 0.114 | 0.021 | 0.166 | Glycine receptor antagonist | 0.166 0.005 CID_21349584 | CID_21349584 | |
| 0.102 | 0.01 | 0.15 | Carbonic anhydrase XIV inhibitor | 0.15 0.005 CID_21349584 | CID_21349584 | |
| 0.115 | 0.024 | 0.115 | Histamine H2 receptor antagonist | |||
| 0.096 | 0.005 | 0.146 | Glucose-6-phosphate isomerase inhibitor | 0.146 0.003 CID_21349584 | CID_21349584 | |
| 0.165 | 0.074 | 0.165 | Catenin beta inhibitor | |||
| 0.131 | 0.04 | 0.392 | AMP-activated protein kinase stimulant | 0.392 0.004 CID_21349584 | CID_21349584 | |
| 0.095 | 0.005 | 0.095 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.023 CID_21349584 | ||
| 0.122 | 0.032 | 0.122 | Androgen antagonist | |||
| 0.11 | 0.021 | 0.11 | Carbonic anhydrase VA inhibitor | |||
| 0.147 | 0.057 | 0.147 | Acetylcholinesterase inhibitor | |||
| 0.093 | 0.004 | 0.093 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.101 | 0.012 | 0.133 | Interferon inducer | 0.133 0.005 CID_21349584 | CID_21349584 | |
| 0.11 | 0.023 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.13 0.011 CID_21349584 | CID_21349584 | |
| 0.107 | 0.021 | 0.107 | Amidase inhibitor | |||
| 0.104 | 0.018 | 0.104 | Argininosuccinate synthase inhibitor | 0.076 0.027 CID_21349584 | ||
| 0.138 | 0.052 | 0.138 | Acetylcholine muscarinic antagonist | |||
| 0.101 | 0.016 | 0.101 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.096 0.018 CID_21349584 | ||
| 0.098 | 0.014 | 0.098 | MAP kinase kinase 7 inhibitor | |||
| 0.107 | 0.023 | 0.107 | GABA aminotransferase inhibitor | 0.098 0.028 CID_21349584 | ||
| 0.093 | 0.01 | 0.093 | CD45 antagonist | |||
| 0.088 | 0.004 | 0.088 | Dopamine autoreceptor agonist | |||
| 0.098 | 0.015 | 0.098 | Androgen agonist | |||
| 0.107 | 0.025 | 0.107 | Aminopeptidase I inhibitor | |||
| 0.101 | 0.02 | 0.101 | CC chemokine 5 receptor agonist | |||
| 0.084 | 0.003 | 0.098 | Uridine phosphorylase inhibitor | 0.098 0.002 CID_21349584 | CID_21349584 | |
| 0.115 | 0.034 | 0.15 | Thioredoxin inhibitor | 0.15 0.017 CID_21349584 | CID_21349584 | |
| 0.109 | 0.029 | 0.141 | ATPase (Vacuolar H+) inhibitor | 0.141 0.01 CID_21349584 | CID_21349584 | |
| 0.09 | 0.011 | 0.09 | Glucosylceramidase inhibitor | 0.063 0.028 CID_21349584 | ||
| 0.137 | 0.059 | 0.137 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.095 | 0.017 | 0.132 | Neuraminidase inhibitor | 0.132 0.008 CID_21349584 | CID_21349584 | |
| 0.084 | 0.007 | 0.084 | Beta 2 adrenoreceptor agonist | |||
| 0.133 | 0.057 | 0.133 | Adenylate cyclase inhibitor | |||
| 0.162 | 0.086 | 0.162 | Tumour necrosis factor antagonist | |||
| 0.163 | 0.088 | 0.163 | Lipocortins synthesis antagonist | 0.153 0.1 CID_21349584 | ||
| 0.076 | 0.002 | 0.076 | Estrogen-related receptor gamma antagonist | |||
| 0.127 | 0.053 | 0.127 | Interleukin 8 antagonist | |||
| 0.084 | 0.01 | 0.257 | Alpha-mannosidase inhibitor | 0.257 0.003 CID_21349584 | CID_21349584 | |
| 0.077 | 0.004 | 0.077 | Leukotriene C4 antagonist | 0.042 0.019 CID_21349584 | ||
| 0.081 | 0.008 | 0.081 | Ryanodine receptor antagonist | |||
| 0.08 | 0.007 | 0.08 | Pregnane X receptor antagonist | |||
| 0.08 | 0.008 | 0.08 | Retinoid X receptor agonist | |||
| 0.079 | 0.007 | 0.079 | Nicotinic acid receptor agonist | |||
| 0.08 | 0.007 | 0.08 | Retinoid X alpha receptor agonist | |||
| 0.076 | 0.005 | 0.076 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.088 | 0.017 | 0.101 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.101 0.014 CID_21349584 | CID_21349584 | |
| 0.074 | 0.004 | 0.159 | Sodium/glucose cotransporter 2 inhibitor | 0.159 0.001 CID_21349584 | CID_21349584 | |
| 0.096 | 0.026 | 0.096 | Potassium channel large-conductance Ca-activated activator | |||
| 0.096 | 0.026 | 0.096 | Calcium channel L-type blocker | |||
| 0.089 | 0.02 | 0.089 | 5 Hydroxytryptamine 2A agonist | |||
| 0.084 | 0.014 | 0.084 | Phosphodiesterase 1A inhibitor | |||
| 0.128 | 0.059 | 0.128 | Proteasome inhibitor | |||
| 0.107 | 0.038 | 0.107 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 CID_21349584 | ||
| 0.082 | 0.013 | 0.082 | Aconitate hydratase inhibitor | |||
| 0.076 | 0.008 | 0.076 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.081 | 0.013 | 0.081 | Oleamide hydrolase inhibitor | |||
| 0.097 | 0.029 | 0.097 | Lipase inhibitor | 0.065 0.059 CID_21349584 | ||
| 0.188 | 0.12 | 0.475 | Tumour necrosis factor alpha release inhibitor | 0.475 0.016 CID_21349584 | CID_21349584 | |
| 0.088 | 0.021 | 0.146 | Neuraminidase (influenza) inhibitor | 0.146 0.008 CID_21349584 | CID_21349584 | |
| 0.073 | 0.006 | 0.11 | Cytokine production stimulant | 0.11 0.004 CID_21349584 | CID_21349584 | |
| 0.143 | 0.076 | 0.458 | Hemostatic | 0.458 0.005 CID_21349584 | CID_21349584 | |
| 0.075 | 0.009 | 0.075 | Cholesterol esterase inhibitor | 0.044 0.04 CID_21349584 | ||
| 0.084 | 0.018 | 0.084 | Heat shock protein 90 beta antagonist | |||
| 0.103 | 0.038 | 0.196 | Topoisomerase II alpha inhibitor | 0.196 0.015 CID_21349584 | CID_21349584 | |
| 0.086 | 0.021 | 0.086 | Glutamate (mGluR7) antagonist | |||
| 0.099 | 0.034 | 0.099 | Vanilloid agonist | |||
| 0.075 | 0.01 | 0.259 | Mannosidase inhibitor | 0.259 0.002 CID_21349584 | CID_21349584 | |
| 0.068 | 0.003 | 0.068 | Prostaglandin F2 alpha agonist | 0.033 0.007 CID_21349584 | ||
| 0.075 | 0.011 | 0.075 | Adenosine deaminase inhibitor | 0.073 0.012 CID_21349584 | ||
| 0.071 | 0.007 | 0.071 | Geranyltranstransferase inhibitor | |||
| 0.068 | 0.004 | 0.224 | Sodium/glucose cotransporter inhibitor | 0.224 0.001 CID_21349584 | CID_21349584 | |
| 0.077 | 0.015 | 0.077 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.066 | 0.004 | 0.066 | Estrogen-related receptor beta antagonist | |||
| 0.079 | 0.016 | 0.079 | Calcium channel P-type blocker | |||
| 0.076 | 0.014 | 0.076 | Purinergic P2Y antagonist | 0.054 0.023 CID_21349584 | ||
| 0.146 | 0.084 | 0.277 | Hexokinase inhibitor | 0.277 0.013 CID_21349584 | CID_21349584 | |
| 0.154 | 0.093 | 0.154 | Dual specificity phosphatase 3 inhibitor | |||
| 0.072 | 0.011 | 0.072 | Leukotriene A4 hydrolase inhibitor | |||
| 0.076 | 0.014 | 0.076 | 5 Hydroxytryptamine 1B agonist | |||
| 0.065 | 0.005 | 0.065 | Retinoid X receptor antagonist | |||
| 0.084 | 0.024 | 0.084 | Biliverdin reductase inhibitor | 0.062 0.038 CID_21349584 | ||
| 0.073 | 0.012 | 0.073 | Vanilloid 2 antagonist | |||
| 0.069 | 0.009 | 0.069 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.133 | 0.073 | 0.138 | Alkaline phosphatase inhibitor | 0.138 0.069 CID_21349584 | CID_21349584 | |
| 0.076 | 0.016 | 0.076 | Plasminogen activator inhibitor antagonist | |||
| 0.091 | 0.032 | 0.091 | Adenosine A3 receptor antagonist | |||
| 0.069 | 0.009 | 0.069 | Liver X receptor alpha agonist | |||
| 0.066 | 0.006 | 0.066 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.065 | 0.006 | 0.065 | Beta adrenoreceptor agonist | |||
| 0.095 | 0.036 | 0.095 | Phosphodiesterase 3A inhibitor | |||
| 0.065 | 0.005 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.138 | 0.079 | 0.138 | MAP3K9 inhibitor | |||
| 0.074 | 0.015 | 0.074 | Epithelial sodium channel blocker | |||
| 0.067 | 0.008 | 0.067 | GABA uptake inhibitor | |||
| 0.069 | 0.012 | 0.069 | Sphingosine 1-phosphate receptor agonist | |||
| 0.096 | 0.038 | 0.096 | mTOR complex 2 inhibitor | |||
| 0.071 | 0.014 | 0.084 | Adenine nucleotide translocase inhibitor | 0.084 0.008 CID_21349584 | CID_21349584 | |
| 0.069 | 0.012 | 0.069 | Dihydroorotase inhibitor | |||
| 0.126 | 0.069 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.064 | 0.008 | 0.064 | Sphingosine kinase 1 inhibitor | |||
| 0.069 | 0.013 | 0.069 | CXC chemokine 1 receptor antagonist | |||
| 0.06 | 0.004 | 0.06 | Glutamate (mGluR3) agonist | 0.033 0.02 CID_21349584 | ||
| 0.111 | 0.056 | 0.271 | Beta glucuronidase inhibitor | 0.271 0.007 CID_21349584 | CID_21349584 | |
| 0.101 | 0.047 | 0.101 | NMDA receptor antagonist | |||
| 0.092 | 0.039 | 0.092 | Caspase 7 inhibitor | |||
| 0.124 | 0.07 | 0.124 | Cholinergic antagonist | |||
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | |||
| 0.058 | 0.005 | 0.058 | Vanilloid 3 antagonist | |||
| 0.08 | 0.028 | 0.08 | Aromatase inhibitor | |||
| 0.058 | 0.006 | 0.058 | Free fatty acid receptor 1 antagonist | |||
| 0.078 | 0.027 | 0.078 | Exportin-1 inhibitor | |||
| 0.057 | 0.006 | 0.057 | Melatonin receptor 1A agonist | |||
| 0.067 | 0.016 | 0.067 | Carbonic anhydrase VII inhibitor | |||
| 0.065 | 0.015 | 0.065 | Adenylate cyclase 1 inhibitor | |||
| 0.082 | 0.032 | 0.082 | Dopamine D1 antagonist | |||
| 0.052 | 0.003 | 0.052 | Estrogen-related receptor gamma agonist | |||
| 0.054 | 0.005 | 0.054 | Retinoid X alpha receptor antagonist | |||
| 0.055 | 0.005 | 0.055 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 CID_21349584 | ||
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | |||
| 0.062 | 0.014 | 0.062 | Dopamine beta hydroxylase inhibitor | |||
| 0.072 | 0.025 | 0.072 | Ornithine carbamoyltransferase inhibitor | 0.051 0.039 CID_21349584 | ||
| 0.063 | 0.016 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.056 | 0.009 | 0.056 | Prostaglandin agonist | 0.028 0.026 CID_21349584 | ||
| 0.057 | 0.01 | 0.057 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.169 | 0.122 | 0.169 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.101 | 0.054 | 0.101 | Breast cancer-resistant protein inhibitor | |||
| 0.057 | 0.011 | 0.057 | Phosphodiesterase 6C inhibitor | |||
| 0.054 | 0.007 | 0.054 | Liver X receptor beta antagonist | |||
| 0.118 | 0.072 | 0.118 | Acetylcholine antagonist | |||
| 0.136 | 0.089 | 0.136 | Cholinergic | |||
| 0.07 | 0.024 | 0.07 | Cannabinoid CB2 receptor antagonist | |||
| 0.108 | 0.063 | 0.255 | Topoisomerase I inhibitor | 0.255 0.016 CID_21349584 | CID_21349584 | |
| 0.053 | 0.008 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.109 | 0.064 | 0.109 | Protein kinase C gamma inhibitor | |||
| 0.115 | 0.071 | 0.268 | Topoisomerase II inhibitor | 0.268 0.022 CID_21349584 | CID_21349584 | |
| 0.1 | 0.056 | 0.1 | MAP kinase kinase 1 inhibitor | |||
| 0.049 | 0.005 | 0.049 | Thyroid hormone agonist | |||
| 0.058 | 0.014 | 0.058 | Glutamate (mGluR group III) antagonist | |||
| 0.061 | 0.016 | 0.061 | Oxytocin agonist | |||
| 0.063 | 0.019 | 0.063 | Immunoglobulin Fc receptor antagonist | |||
| 0.055 | 0.011 | 0.055 | Sirtuin 2 inhibitor | |||
| 0.075 | 0.031 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.053 | 0.01 | 0.053 | Liver X receptor beta agonist | |||
| 0.054 | 0.011 | 0.054 | Glutamate (mGluR3) antagonist | |||
| 0.136 | 0.093 | 0.373 | Thrombolytic | 0.373 0.014 CID_21349584 | CID_21349584 | |
| 0.072 | 0.03 | 0.072 | Acetylcholine M3 receptor antagonist | |||
| 0.133 | 0.091 | 0.133 | Thiol protease inhibitor | |||
| 0.144 | 0.101 | 0.144 | Dual specificity phosphatase inhibitor | |||
| 0.102 | 0.06 | 0.102 | Butyrylcholinesterase inhibitor | |||
| 0.057 | 0.015 | 0.074 | Neuraminidase (Influenza A) inhibitor | 0.074 0.006 CID_21349584 | CID_21349584 | |
| 0.049 | 0.007 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 CID_21349584 | ||
| 0.083 | 0.042 | 0.083 | Metalloproteinase-9 inhibitor | |||
| 0.062 | 0.02 | 0.25 | Heparanase inhibitor | 0.25 0.002 CID_21349584 | CID_21349584 | |
| 0.087 | 0.046 | 0.087 | Thioredoxin reductase inhibitor | |||
| 0.068 | 0.027 | 0.068 | Matrix metalloproteinase 1 inhibitor | |||
| 0.132 | 0.092 | 0.301 | Diuretic | 0.301 0.022 CID_21349584 | CID_21349584 | |
| 0.078 | 0.038 | 0.078 | Matrix metalloproteinase inhibitor | |||
| 0.07 | 0.031 | 0.07 | Acetylcholine M5 receptor antagonist | |||
| 0.082 | 0.042 | 0.082 | Cathepsin G inhibitor | |||
| 0.132 | 0.094 | 0.319 | NOS3 expression enhancer | 0.319 0.015 CID_21349584 | CID_21349584 | |
| 0.055 | 0.017 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CID_21349584 | CID_21349584 | |
| 0.095 | 0.057 | 0.095 | Protein kinase C zeta inhibitor | |||
| 0.058 | 0.021 | 0.058 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.048 | 0.011 | 0.048 | Melatonin 2 agonist | 0.032 0.024 CID_21349584 | ||
| 0.04 | 0.003 | 0.04 | Isoleucine-tRNA ligase inhibitor | 0.037 0.003 CID_21349584 | ||
| 0.083 | 0.047 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.05 | 0.014 | 0.05 | Kainate receptor agonist | |||
| 0.043 | 0.007 | 0.043 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.05 | 0.014 | 0.05 | Heme oxygenase inhibitor | |||
| 0.048 | 0.013 | 0.048 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.068 | 0.033 | 0.068 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.152 | 0.117 | 0.152 | I kappa B kinase epsilon inhibitor | |||
| 0.052 | 0.018 | 0.052 | 5-Alpha-reductase inhibitor | |||
| 0.111 | 0.077 | 0.111 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.07 | 0.104 | Nav1.4 sodium channel blocker | |||
| 0.068 | 0.034 | 0.068 | TRPA1 antagonist | |||
| 0.144 | 0.111 | 0.144 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.12 | 0.086 | 0.12 | Toll-Like receptor 9 antagonist | |||
| 0.068 | 0.035 | 0.092 | Nitric oxide donor | 0.092 0.013 CID_21349584 | CID_21349584 | |
| 0.037 | 0.004 | 0.083 | Ileal bile acid transport inhibitor | 0.083 0.002 CID_21349584 | CID_21349584 | |
| 0.043 | 0.01 | 0.043 | Phosphodiesterase 6B inhibitor | |||
| 0.054 | 0.022 | 0.054 | NMDA receptor subunit 3B antagonist | |||
| 0.037 | 0.005 | 0.06 | Vanilloid 2 agonist | 0.06 0.002 CID_21349584 | CID_21349584 | |
| 0.051 | 0.019 | 0.051 | Dopamine D3 agonist | |||
| 0.067 | 0.034 | 0.067 | Collagenase 3 inhibitor | |||
| 0.037 | 0.005 | 0.037 | Leukotriene B4 receptor 2 antagonist | 0.034 0.007 CID_21349584 | ||
| 0.075 | 0.043 | 0.075 | Phospholipase D inhibitor | |||
| 0.05 | 0.018 | 0.05 | Dihydrofolate reductase inhibitor | |||
| 0.074 | 0.044 | 0.074 | Secretase beta inhibitor | |||
| 0.035 | 0.005 | 0.035 | Phosphodiesterase 6A inhibitor | |||
| 0.045 | 0.015 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.077 | 0.047 | 0.077 | Vanilloid 4 agonist | |||
| 0.081 | 0.051 | 0.081 | Metalloproteinase-2 inhibitor | |||
| 0.041 | 0.012 | 0.041 | Cholesterol ester transfer protein antagonist | |||
| 0.102 | 0.073 | 0.102 | 5 Hydroxytryptamine 3A agonist | |||
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | 0.035 0.023 CID_21349584 | ||
| 0.062 | 0.033 | 0.062 | Fatty acid synthase inhibitor | |||
| 0.064 | 0.036 | 0.064 | Cyclin D1 inhibitor | |||
| 0.064 | 0.036 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.055 | 0.028 | 0.055 | Metalloproteinase-3 inhibitor | |||
| 0.065 | 0.038 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.036 | 0.01 | 0.036 | Prostaglandin EP2 agonist | |||
| 0.035 | 0.009 | 0.035 | Prostaglandin E2 agonist | |||
| 0.047 | 0.02 | 0.047 | Plasmepsin II inhibitor | |||
| 0.048 | 0.022 | 0.048 | GABA B receptor antagonist | |||
| 0.063 | 0.037 | 0.063 | Adenosine A1 receptor antagonist | |||
| 0.033 | 0.007 | 0.033 | Beta 1 adrenoreceptor agonist | |||
| 0.075 | 0.049 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.034 | 0.008 | 0.034 | Hedgehog signaling activator | |||
| 0.045 | 0.019 | 0.045 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.085 | 0.059 | 0.179 | Transcription factor NF kappa B stimulant | 0.179 0.011 CID_21349584 | CID_21349584 | |
| 0.081 | 0.056 | 0.081 | Opioid kappa receptor antagonist | |||
| 0.03 | 0.004 | 0.03 | Retinoid X beta receptor antagonist | |||
| 0.039 | 0.014 | 0.039 | ATP citrate lysase inhibitor | |||
| 0.058 | 0.034 | 0.058 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.048 | 0.024 | 0.048 | Glutamate (mGluR4) antagonist | |||
| 0.057 | 0.033 | 0.057 | Dihydroorotate oxidase inhibitor | |||
| 0.055 | 0.031 | 0.111 | Glucose-6-phosphate translocase inhibitor | 0.111 0.005 CID_21349584 | CID_21349584 | |
| 0.06 | 0.036 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 CID_21349584 | CID_21349584 | |
| 0.066 | 0.042 | 0.066 | CDC25B inhibitor | |||
| 0.086 | 0.062 | 0.086 | Opioid antagonist | |||
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | |||
| 0.057 | 0.033 | 0.057 | Thromboxane synthase inhibitor | |||
| 0.056 | 0.034 | 0.056 | Alpha tubulin antagonist | |||
| 0.115 | 0.093 | 0.115 | Calcium channel blocker | |||
| 0.047 | 0.025 | 0.047 | Toll-Like receptor 2 agonist | 0.046 0.026 CID_21349584 | ||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | |||
| 0.027 | 0.005 | 0.027 | Thyroid hormone alpha antagonist | |||
| 0.026 | 0.005 | 0.026 | NMDA receptor phencyclidine site antagonist | |||
| 0.035 | 0.013 | 0.035 | Leukotriene D4 antagonist | |||
| 0.069 | 0.048 | 0.069 | Elastase 1 inhibitor | |||
| 0.032 | 0.01 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.045 | 0.024 | 0.045 | Acetyl-CoA carboxylase inhibitor | |||
| 0.047 | 0.026 | 0.047 | Leukocyte elastase inhibitor | |||
| 0.059 | 0.038 | 0.059 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase inhibitor | |||
| 0.031 | 0.012 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 CID_21349584 | CID_21349584 | |
| 0.036 | 0.016 | 0.036 | Glucagon receptor antagonist | |||
| 0.071 | 0.052 | 0.071 | Epoxide hydrolase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.046 | 0.027 | 0.046 | Liver X receptor agonist | |||
| 0.03 | 0.011 | 0.03 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.024 | 0.006 | 0.038 | Antibiotic Anthracycline-like | 0.038 0.003 CID_21349584 | CID_21349584 | |
| 0.054 | 0.036 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.062 | 0.045 | 0.062 | Opioid delta receptor antagonist | |||
| 0.103 | 0.086 | 0.127 | Beta amyloid protein antagonist | 0.127 0.061 CID_21349584 | CID_21349584 | |
| 0.032 | 0.015 | 0.032 | Thiazolidinedione | |||
| 0.063 | 0.046 | 0.063 | Transcription factor RelA inhibitor | |||
| 0.04 | 0.024 | 0.04 | 5 Hydroxytryptamine 2B agonist | |||
| 0.056 | 0.039 | 0.056 | 5 Hydroxytryptamine 7 agonist | |||
| 0.072 | 0.056 | 0.072 | Potassium channel (Tandem pore domain) blocker | |||
| 0.036 | 0.02 | 0.036 | Melatonin 1 agonist | |||
| 0.021 | 0.006 | 0.021 | Vitamin D receptor agonist | 0.019 0.007 CID_21349584 | ||
| 0.071 | 0.056 | 0.071 | CDC25A inhibitor | |||
| 0.021 | 0.006 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_21349584 | CID_21349584 | |
| 0.028 | 0.013 | 0.028 | Acid ceramidase inhibitor | |||
| 0.04 | 0.026 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.031 | 0.017 | 0.031 | Liver X receptor alpha antagonist | |||
| 0.022 | 0.007 | 0.022 | Nicotinic acid receptor 1 antagonist | |||
| 0.023 | 0.008 | 0.023 | Prostaglandin EP4 agonist | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.026 | 0.012 | 0.026 | Phosphodiesterase 6G inhibitor | |||
| 0.026 | 0.012 | 0.026 | Phosphodiesterase 6H inhibitor | |||
| 0.054 | 0.04 | 0.054 | Maillard reaction inhibitor | |||
| 0.047 | 0.033 | 0.047 | Benzodiazepine antagonist | |||
| 0.058 | 0.045 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.039 | 0.026 | 0.039 | NMDA receptor subunit 3A antagonist | |||
| 0.029 | 0.015 | 0.029 | Retinoid X gamma receptor antagonist | |||
| 0.052 | 0.038 | 0.052 | Alpha 1L adrenoreceptor antagonist | |||
| 0.019 | 0.006 | 0.019 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.037 | 0.025 | 0.074 | Arginase inhibitor | 0.074 0.007 CID_21349584 | CID_21349584 | |
| 0.052 | 0.04 | 0.052 | Thromboxane antagonist | |||
| 0.056 | 0.045 | 0.076 | Prostaglandin EP2 antagonist | 0.076 0.029 CID_21349584 | CID_21349584 | |
| 0.052 | 0.041 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.108 | 0.096 | 0.108 | Phosphodiesterase inhibitor | |||
| 0.038 | 0.027 | 0.038 | Glutamate (mGluR group II) antagonist | |||
| 0.091 | 0.081 | 0.091 | Glutamate (mGluR7) agonist | |||
| 0.02 | 0.009 | 0.02 | G-protein-coupled receptor 120 agonist | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | |||
| 0.021 | 0.011 | 0.021 | Caspase 8 inhibitor | |||
| 0.037 | 0.027 | 0.037 | Farnesoid X receptor agonist | |||
| 0.033 | 0.024 | 0.033 | Calcitonin receptor agonist | |||
| 0.075 | 0.066 | 0.075 | Acetylcholine M3 receptor agonist | |||
| 0.047 | 0.038 | 0.047 | Thromboxane A2 antagonist | |||
| 0.056 | 0.048 | 0.056 | Acetylcholine M2 receptor antagonist | |||
| 0.021 | 0.012 | 0.021 | Retinoic acid beta receptor agonist | |||
| 0.015 | 0.007 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.061 | 0.053 | 0.061 | Opioid mu receptor antagonist | |||
| 0.032 | 0.024 | 0.032 | Catechol O-methyltransferase inhibitor | |||
| 0.056 | 0.049 | 0.056 | Adenosine A2a receptor antagonist | |||
| 0.146 | 0.139 | 0.146 | Aryl hydrocarbon receptor agonist | |||
| 0.019 | 0.012 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | |||
| 0.031 | 0.025 | 0.031 | Melatonin agonist | |||
| 0.047 | 0.041 | 0.047 | NMDA 2A receptor antagonist | |||
| 0.037 | 0.031 | 0.037 | Retinoic acid alpha receptor agonist | |||
| 0.011 | 0.005 | 0.011 | Thyroid hormone beta agonist | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.048 | 0.043 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.046 | 0.041 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.012 | 0.007 | 0.012 | Beta 3 adrenoreceptor agonist | |||
| 0.048 | 0.044 | 0.048 | Ribonucleotide reductase inhibitor | |||
| 0.035 | 0.03 | 0.035 | Diamine oxidase inhibitor | |||
| 0.021 | 0.018 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.021 | 0.017 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.03 | 0.026 | 0.03 | Estrogen-related receptor alpha antagonist | |||
| 0.036 | 0.033 | 0.036 | MAP3K5 inhibitor | |||
| 0.072 | 0.07 | 0.072 | Phosphodiesterase IV inhibitor | |||
| 0.046 | 0.043 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.031 | 0.028 | 0.031 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.039 | 0.036 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.029 | 0.027 | 0.029 | Prostacyclin antagonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.028 | 0.026 | 0.067 | Squalene synthetase inhibitor | 0.067 0.01 CID_21349584 | CID_21349584 | |
| 0.046 | 0.045 | 0.046 | Potassium channel (Inward rectifier) activator | |||
| 0.028 | 0.027 | 0.028 | HCV NS5B polymerase inhibitor | |||
| 0.07 | 0.069 | 0.07 | Acetylcholine nicotinic antagonist | |||
| 0.036 | 0.035 | 0.036 | Dopamine D5 antagonist | |||
| 0.058 | 0.057 | 0.058 | Aryl hydrocarbon receptor antagonist | |||
| 0.022 | 0.021 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.024 | 0.023 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.044 | 0.043 | 0.044 | Potassium channel (ATP-sensitive) activator | |||
| 0.025 | 0.024 | 0.025 | Cyclin E2 inhibitor | |||
| 0.026 | 0.025 | 0.026 | Glucosylceramidase stimulant | |||
| 0.02 | 0.021 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 CID_21349584 | CID_21349584 | |
| 0.256 | 0.26 | 0.78 | Antiinflammatory | 0.78 0.018 CID_21349584 | CID_21349584 | |
| 0.052 | 0.057 | 0.416 | Selectin antagonist | 0.416 0.003 CID_21349584 | CID_21349584 | |
| 0.007 | 0.017 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_21349584 | CID_21349584 | |
| 0.038 | 0.054 | 0.08 | Aldose reductase inhibitor | 0.08 0.023 CID_21349584 | CID_21349584 | |
| 0.085 | 0.101 | 0.097 | Folate antagonist | 0.097 0.07 CID_21349584 | CID_21349584 | |
| 0.042 | 0.064 | 0.056 | Factor III inhibitor | 0.056 0.023 CID_21349584 | CID_21349584 | |
| 0.031 | 0.055 | 0.073 | Carbonic anhydrase XII inhibitor | 0.073 0.028 CID_21349584 | CID_21349584 | |
| 0.013 | 0.039 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_21349584 | CID_21349584 | |
| 0.015 | 0.042 | 0.024 | Dopamine D1 agonist | 0.024 0.013 CID_21349584 | CID_21349584 | |
| 0.031 | 0.06 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.042 CID_21349584 | CID_21349584 | |
| 0.015 | 0.046 | 0.068 | Protein 30S ribosomal subunit inhibitor | 0.068 0.005 CID_21349584 | CID_21349584 | |
| 0.025 | 0.067 | 0.085 | Antibiotic Aminoglycoside-like | 0.085 0.004 CID_21349584 | CID_21349584 | |
| 0.046 | 0.09 | 0.223 | Antineoplastic antibiotic | 0.223 0.017 CID_21349584 | CID_21349584 | |
| 0.079 | 0.124 | 0.116 | Multidrug resistance-associated protein 1 inhibitor | 0.116 0.053 CID_21349584 | CID_21349584 | |
| 0.019 | 0.067 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 CID_21349584 | CID_21349584 | |
| 0.002 | 0.062 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 CID_21349584 | CID_21349584 | |
| 0.022 | 0.083 | 0.08 | Phosphorylase inhibitor | 0.08 0.017 CID_21349584 | CID_21349584 | |
| 0.157 | 0.224 | 0.534 | Immunomodulator | 0.534 0.019 CID_21349584 | CID_21349584 | |
| 0.169 | 0.248 | 0.322 | Antiobesity | 0.322 0.102 CID_21349584 | CID_21349584 | |
| 0.026 | 0.106 | 0.051 | Microtubule stabilization | 0.051 0.026 CID_21349584 | CID_21349584 | |
| 0.008 | 0.09 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_21349584 | CID_21349584 | |
| 0.058 | 0.151 | 0.147 | DNA intercalator | 0.147 0.044 CID_21349584 | CID_21349584 | |
| 0.074 | 0.178 | 0.343 | Cell adhesion inhibitor | 0.343 0.008 CID_21349584 | CID_21349584 | |
| 0.106 | 0.22 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 CID_21349584 | CID_21349584 | |
| 0.037 | 0.153 | 0.091 | Histone deacetylase SIRT1 stimulant | 0.091 0.034 CID_21349584 | CID_21349584 | |
| 0.037 | 0.153 | 0.091 | Histone deacetylase stimulant | 0.091 0.034 CID_21349584 | CID_21349584 | |
| 0.02 | 0.151 | 0.116 | Protein 50S ribosomal subunit inhibitor | 0.116 0.01 CID_21349584 | CID_21349584 | |
| 0.026 | 0.182 | 0.104 | Factor IXa inhibitor | 0.104 0.009 CID_21349584 | CID_21349584 | |
| 0.041 | 0.241 | 0.171 | Cell adhesion molecule inhibitor | 0.171 0.012 CID_21349584 | CID_21349584 | |
| 0.041 | 0.262 | 0.088 | Falcipain inhibitor | 0.088 0.064 CID_21349584 | CID_21349584 | |
| 0.04 | 0.263 | 0.085 | Falcipain 2 inhibitor | 0.085 0.064 CID_21349584 | CID_21349584 | |
| 0.042 | 0.414 | 0.089 | T cell inhibitor | 0.089 0.04 CID_21349584 | CID_21349584 | |
| 0.032 | 0.419 | 0.257 | Anticoagulant | 0.257 0.037 CID_21349584 | CID_21349584 | |
| 0.061 | 0.451 | 0.24 | Angiogenesis inhibitor | 0.24 0.131 CID_21349584 | CID_21349584 | |
| 0.005 | 0.443 | 0.022 | Motilin receptor agonist | 0.022 0.017 CID_21349584 | CID_21349584 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |